Lee‐Ming Chuang

ORCID: 0000-0003-0978-2662
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Management and Research
  • Genetic Associations and Epidemiology
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Adipose Tissue and Metabolism
  • Adipokines, Inflammation, and Metabolic Diseases
  • Liver Disease Diagnosis and Treatment
  • Metabolomics and Mass Spectrometry Studies
  • Diabetes Management and Education
  • Peroxisome Proliferator-Activated Receptors
  • Diet, Metabolism, and Disease
  • RNA modifications and cancer
  • Lipid metabolism and disorders
  • Diet and metabolism studies
  • Bariatric Surgery and Outcomes
  • Chronic Kidney Disease and Diabetes
  • Microbial metabolism and enzyme function
  • Blood Pressure and Hypertension Studies
  • Cancer, Hypoxia, and Metabolism
  • Alcohol Consumption and Health Effects
  • Inflammatory mediators and NSAID effects
  • Regulation of Appetite and Obesity

National Taiwan University Hospital
2016-2025

National Taiwan University
2016-2025

National Yang Ming Chiao Tung University
2007-2023

Chung Shan Hospital
2021

Beth Israel Deaconess Medical Center
2021

Mitsubishi Corporation (Japan)
2015-2016

Taipei Institute of Pathology
2003-2016

SK Group (Japan)
2015

JW Pharmaceutical (South Korea)
2015

Icahn School of Medicine at Mount Sinai
2015

Adiponectin, an adipose tissue-specific plasma protein, was recently revealed to have anti-inflammatory effects on the cellular components of vascular wall. Its levels were significantly lower in men than women and human subjects with obesity, type 2 diabetes mellitus, or coronary artery disease. Therefore, it may provide a biological link between obesity obesity-related disorders such as atherosclerosis, against which confer protection. In this study, we observed changes adiponectin body...

10.1210/jcem.86.8.7741 article EN The Journal of Clinical Endocrinology & Metabolism 2001-08-01

<h3>Importance</h3>Controlling glycemia, blood pressure, and cholesterol is important for patients with diabetes. How best to achieve this goal unknown.<h3>Objective</h3>To compare Roux-en-Y gastric bypass lifestyle intensive medical management control of comorbid risk factors.<h3>Design, Setting, Participants</h3>A 12-month, 2-group unblinded randomized trial at 4 teaching hospitals in the United States Taiwan involving 120 participants who had a hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>)...

10.1001/jama.2013.5835 article EN JAMA 2013-06-05

OBJECTIVE—Adiponectin, a plasma protein exclusively synthesized and secreted by adipose tissue, has recently been shown to have anti-inflammatory, antiatherogenic properties in vitro beneficial metabolic effects animals. Lower levels of adiponectin documented human subjects with syndrome coronary artery disease. We investigated whether the level this putative protective adipocytokine could be increased treatment peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist diabetic patients....

10.2337/diacare.25.2.376 article EN Diabetes Care 2002-02-01

To investigate the underlying mechanisms of T2D pathogenesis, we looked for diabetes susceptibility genes that increase risk type 2 (T2D) in a Han Chinese population. A two-stage genome-wide association (GWA) study was conducted, which 995 patients and 894 controls were genotyped using Illumina HumanHap550-Duo BeadChip first genome scan stage. This further replicated 1,803 1,473 stage 2. We found two loci not previously associated with around protein tyrosine phosphatase receptor D (PTPRD)...

10.1371/journal.pgen.1000847 article EN cc-by PLoS Genetics 2010-02-18

<h3>Importance</h3> The Roux-en-Y gastric bypass is effective in achieving established diabetes treatment targets, but durability unknown. <h3>Objective</h3> To compare of added to intensive lifestyle and medical management control targets. <h3>Design, Setting, Participants</h3> Observational follow-up a randomized clinical trial at 4 sites the United States Taiwan, involving 120 participants who had hemoglobin A<sub>1c</sub>(HbA<sub>1c</sub>) level 8.0% or higher body mass index between...

10.1001/jama.2017.20813 article EN JAMA 2018-01-16

Background— Microvascular renal and retinal diseases are common major complications of type 2 diabetes mellitus. The relation between plasma lipids microvascular disease is not well established. Methods Results— case subjects were 2535 patients with mellitus an average duration 14 years, 1891 whom had kidney 1218 retinopathy. matched for duration, age, sex, low-density lipoprotein cholesterol to 3683 control who did have or study was conducted in 24 sites 13 countries. primary analysis...

10.1161/circulationaha.113.002529 article EN Circulation 2013-12-19
Pradeep Natarajan Gina M. Peloso Seyedeh M. Zekavat May E. Montasser Andrea Ganna and 95 more Mark Chaffin Amit V. Khera Wei Zhou Jonathan M. Bloom J Engreitz Jason Ernst Jeffrey R. O’Connell Sanni Ruotsalainen Maris Alver Ani Manichaikul W. Craig Johnson James A. Perry Timothy Poterba Cotton Seed Ida Surakka Tõnu Esko Samuli Ripatti Veikko Salomaa Adolfo Correa Ramachandran S. Vasan Manolis Kellis Benjamin M. Neale Eric S. Lander Gonçalo R. Abecasis Braxton D. Mitchell Stephen S. Rich James G. Wilson L. Adrienne Cupples Jerome I. Rotter Cristen J. Willer Sekar Kathiresan Namiko Abe Christine M. Albert Nicholette Palmer Allred Laura Almasy Álvaro Alonso Seth A. Ament Peter Anderson Pramod Anugu Deborah Applebaum‐Bowden Dan E. Arking Donna K. Arnett Allison E. Ashley‐Koch Stella Aslibekyan Tim Assimes Paul L. Auer Dimitrios Avramopoulos J. A. Barnard Kathleen C. Barnes R. Graham Barr Emily Barron‐Casella Terri H. Beaty Diane M. Becker Lewis C. Becker Rebecca Beer Ferdouse Begum Amber L. Beitelshees Emelia J. Benjamin Marcos Bezerra Larry Bielak Joshua C. Bis Thomas W. Blackwell John Blangero Eric Boerwinkle Ingrid B. Borecki Russell P. Bowler Jennifer A. Brody Ulrich Broeckel Jai Broome Karen Bunting Esteban Burchard Jonathan Cardwell Cara L. Carty Richard Casaburi James F. Casella Christy Chang Daniel I. Chasman Sameer Chavan Bo-Juen Chen Wei‐Min Chen Yii-Der Ida Chen Michael H. Cho Seung Hoan Choi Lee‐Ming Chuang Mina K. Chung Elaine Cornell Carolyn Crandall James D. Crapo Joanne E. Curran Jeffrey L. Curtis Brian Custer Coleen Damcott Dawood Darbar Sayantan Das Sean P. David

Large-scale deep-coverage whole-genome sequencing (WGS) is now feasible and offers potential advantages for locus discovery. We perform WGS in 16,324 participants from four ancestries at mean depth >29X analyze genotypes with quantitative traits-plasma total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density triglycerides. Common variant association yields known loci except few variants previously poorly imputed. Rare coding Mendelian dyslipidemia genes but rare...

10.1038/s41467-018-05747-8 article EN cc-by Nature Communications 2018-08-17
Ken Suzuki Konstantinos Hatzikotoulas Lorraine Southam Henry J. Taylor Xianyong Yin and 95 more Kimberly Lorenz Ravi Mandla Alicia Huerta-Chagoya Giorgio Melloni Stavroula Kanoni Nigel W. Rayner Ozvan Bocher Ana Luiza Arruda Kyuto Sonehara Shinichi Namba Simon S. K. Lee Michael Preuß Lauren E. Petty Philip Schroeder Brett Vanderwerff Mart Kals Fiona Bragg Kuang Lin Xiuqing Guo Weihua Zhang Jie Yao Young Jin Kim Mariaelisa Graff Fumihiko Takeuchi Jana Nano Amel Lamri Masahiro Nakatochi Sanghoon Moon Robert A. Scott James P. Cook Jung‐Jin Lee Ian Pan Daniel Taliun Esteban J. Parra Jin Fang Chai Lawrence F. Bielak Yasuharu Tabara Yang Hai Guðmar Þorleifsson Niels Grarup Tamar Sofer Matthias Wuttke Chloé Sarnowski Christian Gieger Darryl Nousome Stella Trompet Soo‐Heon Kwak Jirong Long Meng Sun Tong Lin Wei‐Min Chen Suraj S. Nongmaithem Raymond Noordam Victor Lim Claudia H.T. Tam Yoonjung Yoonie Joo Chien-Hsiun Chen Laura M. Raffield Bram P. Prins Aude Nicolas Lisa R. Yanek Guanjie Chen Jennifer A. Brody Edmond K. Kabagambe Ping An Anny H. Xiang Hyeok Sun Choi Brian E. Cade Jingyi Tan K. Alaine Broadaway Alice Williamson Zoha Kamali Jinrui Cui Manonanthini Thangam Linda S. Adair Adebowale Adeyemo Carlos A. Aguilar‐Salinas Tarunveer S. Ahluwalia Sonia S. Anand Alain G. Bertoni Jette Bork‐Jensen Ivan Brandslund Thomas A. Buchanan Charles Burant Adam S. Butterworth Mickaël Canouil Juliana C.N. Chan Li-Ching Chang Miao-Li Chee Ji Chen Shyh‐Huei Chen Yuan‐Tsong Chen Zhengming Chen Lee‐Ming Chuang Mary Cushman

Abstract Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes 1,2 and molecular mechanisms are often specific to cell type 3,4 . Here, characterize the genetic contribution these across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases T2D. We identify 1,289 independent signals at significance ( P &lt; 5 × 10 −8 ) map 611 loci, which 145...

10.1038/s41586-024-07019-6 article EN cc-by Nature 2024-02-19
Yang Luo Masahiro Kanai Wanson Choi Xinyi Li Saori Sakaue and 95 more Kenichi Yamamoto Kotaro Ogawa María Gutiérrez‐Arcelus Peter K. Gregersen Philip E. Stuart James T. Elder Lukas Forer Sebastian Schönherr Christian Fuchsberger Albert V. Smith Jacques Fellay Mary Carrington David W. Haas Xiuqing Guo Nicholette D. Palmer Yii‐Der Ida Chen Jerome I. Rotter Kent D. Taylor Stephen S. Rich Adolfo Correa James G. Wilson Sekar Kathiresan Michael H. Cho Andres Metspalu Tõnu Esko Yukinori Okada Buhm Han Namiko Abe Gonçalo R. Abecasis François Aguet Christine M. Albert Laura Almasy Álvaro Alonso Seth A. Ament Peter Anderson Pramod Anugu Deborah Applebaum‐Bowden Kristin Ardlie Dan E. Arking Donna K. Arnett Allison E. Ashley‐Koch Stella Aslibekyan Tim Assimes Paul L. Auer Dimitrios Avramopoulos Najib Ayas Adithya Balasubramanian John Barnard Kathleen C. Barnes R. Graham Barr Emily Barron‐Casella Lucas Barwick Terri H. Beaty Gerald J. Beck Diane M. Becker Lewis C. Becker Rebecca Beer Amber L. Beitelshees Emelia J. Benjamin Takis Benos Marcos Bezerra Larry Bielak Joshua C. Bis Thomas W. Blackwell John Blangero Eric Boerwinkle Donald W. Bowden Russell P. Bowler Jennifer A. Brody Ulrich Broeckel Jai Broome Deborah Brown Karen Bunting Esteban Burchard Carlos D. Bustamante Erin Buth Brian E. Cade Jonathan Cardwell Vincent J. Carey Julie Carrier Cara L. Carty Richard Casaburi Juan P. Romero James F. Casella Peter J. Castaldi Mark Chaffin Christy Chang Yi–Cheng Chang Daniel I. Chasman Sameer Chavan Bo‐Juen Chen Wei‐Min Chen Seung Hoan Choi Lee‐Ming Chuang Mina K. Chung

10.1038/s41588-021-00935-7 article EN Nature Genetics 2021-10-01

Abstract Several recent advances provide multiple health benefits to individuals with type 2 diabetes mellitus (T2DM). Pharmacological therapy is governed by person‐centered factors, including comorbidities and treatment goals. Adults T2DM who have an established/high risk of atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney require a regimen that includes agents are proven reduce cardiorenal risk. Weight management plays key role in reducing glucose for patients...

10.1002/kjm2.12800 article EN cc-by-nc-nd The Kaohsiung Journal of Medical Sciences 2024-01-06

OBJECTIVE—To study the effect of birth weight on risk type 2 diabetes in schoolchildren Taiwan. RESEARCH DESIGN AND METHODS—From 1992 to 1997, all aged 6–18 years were screened for Taiwan Province. This cohort consisted 1,966 patients with and 1,780 randomly selected subjects normal fasting glycemia (NFG). Questionnaire interviewing was designed classify diabetes. The obtained from Taiwan’s Birth Registry. After merging data, there 978 subjects, including 429 549 NFG enrolled present...

10.2337/diacare.26.2.343 article EN Diabetes Care 2003-02-01

Abstract Objective: Hypoadiponectin has been documented in subjects with obesity, diabetes mellitus, or coronary heart disease, suggesting a potential use of plasma adiponectin following the clinical progress metabolic syndrome (MS). In this study, we investigated levels relation to variables MS among overweight/obese Asian subjects. Research Methods and Procedures: The adiponectin, anthropometric biochemical measurements, oral glucose tolerance tests (OGTT), modified insulin suppression...

10.1038/oby.2002.150 article EN Obesity Research 2002-11-01

Genetic variants in the fat mass and obesity-associated (FTO) gene have been linked with obesity type 2 diabetes European populations. We aimed to test role of FTO genetic Chinese population.

10.2337/db08-0377 article EN cc-by-nc-nd Diabetes 2008-05-17

To find clinically meaningful preoperative predictors of diabetes remission and conversely inadequate glycemic control after gastric bypass surgery. Predicting the improvement in those with type 2 bariatric surgery may help patient selection.Preoperative details 154 ethnic Chinese subjects were examined for their influence on outcomes at 1 year bypass. Remission was defined as HbA(1c) ≤6%. Analysis involved binary logistic regression to identify provide equations receiver operating...

10.2337/dc12-0779 article EN cc-by-nc-nd Diabetes Care 2012-10-02

Waist circumference (WC) is used to define central obesity. This study aimed compare the performance of two recommended locations WC measurement.A cohort 1,898 subjects who were without diabetes from 2006 2012 followed for a median 31 months (Taiwan Lifestyle Study). The WC-IC, by National Cholesterol Education Program Third Adult Treatment Panel, was measured at superior border iliac crest, and WC-mid, World Health Organization International Diabetes Federation, midway between lowest ribs...

10.2337/dc12-1452 article EN cc-by-nc-nd Diabetes Care 2012-12-29

Genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene is one few validated genetic variants with large effects on risk type diabetes in populations European ancestry. In this study, we aimed to explore effect TCF7L2 a Han Chinese population.We genotyped 20 single nucleotide (SNPs) across 1,520 unrelated subjects from population Taiwan. The associations SNPs and haplotypes linkage disequilibrium (LD) structure were analyzed.The previously reported rs7903146 T- rs12255372...

10.2337/db07-0421 article EN Diabetes 2007-09-05
Coming Soon ...